MedTrace Logo

ActivityChoice: Implementing Clinic-Based Physical Activity Program Choices for Cancer Survivors

NCT05870176 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 114

Last updated 2025-11-04

No results posted yet for this study

Summary

Cardiovascular disease, the number one leading cause of death in the United States, is highly prevalent in cancer survivors. Physical activity can reduce risk, and referrals to programs addressing survivors' choices are highly recommended from providers in cancer survivorship, though rarely implemented. The study team proposes to develop ActivityChoice, a clinic-based implementation program, using patient narrative decision aids to support choices to a group in-person, group virtual, or self-monitored digital health physical activity program.

Conditions

Interventions

BEHAVIORAL

Enhanced Referral

The enhanced referral uses an electronic referral and patient decision aid to provide choices to 3 different physical activity programs.

BEHAVIORAL

Standard Referral

The standard referral period will serve as the "usual care" comparator. Patients will receive a paper referral and Fitbit monitor.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of Massachusetts, Worcester

    lead OTHER

Principal Investigators

  • Jamie M Faro, PhD · UMass Chan Medical School

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-11
Primary Completion
2026-08-01
Completion
2026-11-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05870176 on ClinicalTrials.gov